entertainment -WSS

entertainment

author：leisure time 2025-09-27 13:04:04 - browse：913

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Medicare wants to send $9 billion to 340B hospitals

knowledge

WSS

Lack of darker skin in textbooks, journals harms patients of color

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

The aspartame in Diet Coke probably isn’t giving you cancer

Pandemic and All Hazards Preparedness Act needs lean update

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

The cancer drug shortage isn’t new — and neither are the solutions

Why you get paid to donate plasma but not blood

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Apple is now the first public company to be valued at $3 trillion

Johnson & Johnson sues to stop Medicare negotiation

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Wikipedia

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

15 die by electrocution after transformer explodes in northern India

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

The U.S. needs a new definition of substance use “recovery”

Judge agrees to delay next hearing in Trump classified documents case

A strong 6.5

entertainment

knowledge

knowledge

hotspot